China’s pharmaceutical innovation took center stage on Thursday as Vice-Premier Liu Guozhong called for strengthened efforts in research and development. During his visit to Peking University’s School of Pharmaceutical Sciences, Liu emphasized the need for faster breakthroughs in medical science.
Liu is also a member of the Political Bureau of the Communist Party of China Central Committee. He toured key laboratories, reviewed ongoing projects, and attended a symposium with academic, policy, and healthcare experts.
Liu stressed that China’s pharmaceutical innovation must become more dynamic to support the nation’s Healthy China initiative. He said stronger collaboration among researchers, institutions, and companies will drive impactful outcomes. Furthermore, research should focus on people’s health and be backed by targeted policies.
He highlighted the significant momentum in China’s pharmaceutical innovation in recent years. However, he urged continued investment and coordination. Liu encouraged researchers to tap into technologies like artificial intelligence and big data. These tools can speed up development in life sciences and health databases.
Moreover, Liu said universities, companies, and medical institutions should break down barriers and form united research networks. Joint projects will boost efficiency and encourage medical breakthroughs that directly impact public health.
He also called for expanding China’s international role in the medical sector. Deeper global collaboration, according to Liu, is vital for advancing drug development and sharing best practices. He added that China must engage with foreign partners to promote shared health goals and innovation.
In addition, Liu encouraged a more open environment for medical technology exchange. He believes that high-level openness and international cooperation will enhance the quality of China’s healthcare innovations.
Officials at the event praised the central government’s continued support for the pharmaceutical industry. They also discussed how improved lab infrastructure and research funding can unlock new opportunities.
China’s pharmaceutical innovation will play a key role in building a healthier society. Liu concluded that cross-sector coordination, global partnerships, and cutting-edge technology are crucial for future success. These efforts will help China improve lives and maintain long-term public health resilience.
